Bright Minds Biosciences Stock Market Value
| DRUG Stock | USD 80.57 2.65 3.40% |
| Symbol | Bright |
Can Biotechnology industry sustain growth momentum? Does Bright have expansion opportunities? Factors like these will boost the valuation of Bright Minds. Projected growth potential of Bright fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Bright Minds demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Bright Minds Biosciences's market price often diverges from its book value, the accounting figure shown on Bright's balance sheet. Smart investors calculate Bright Minds' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Since Bright Minds' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Bright Minds' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bright Minds should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bright Minds 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bright Minds' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bright Minds.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Bright Minds on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Bright Minds Biosciences or generate 0.0% return on investment in Bright Minds over 90 days. Bright Minds is related to or competes with LB Pharmaceuticals, Design Therapeutics, Aura Biosciences, EnGene Holdings, DiaMedica Therapeutics, Altimmune, and Annexon. Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT medicines to improve the lives of patie... More
Bright Minds Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bright Minds' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bright Minds Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.1 | |||
| Information Ratio | 0.1078 | |||
| Maximum Drawdown | 22.73 | |||
| Value At Risk | (5.73) | |||
| Potential Upside | 9.03 |
Bright Minds Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bright Minds' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bright Minds' standard deviation. In reality, there are many statistical measures that can use Bright Minds historical prices to predict the future Bright Minds' volatility.| Risk Adjusted Performance | 0.1099 | |||
| Jensen Alpha | 0.4186 | |||
| Total Risk Alpha | 0.1673 | |||
| Sortino Ratio | 0.1225 | |||
| Treynor Ratio | 0.2622 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bright Minds' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bright Minds February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1099 | |||
| Market Risk Adjusted Performance | 0.2722 | |||
| Mean Deviation | 3.46 | |||
| Semi Deviation | 3.64 | |||
| Downside Deviation | 4.1 | |||
| Coefficient Of Variation | 799.08 | |||
| Standard Deviation | 4.66 | |||
| Variance | 21.72 | |||
| Information Ratio | 0.1078 | |||
| Jensen Alpha | 0.4186 | |||
| Total Risk Alpha | 0.1673 | |||
| Sortino Ratio | 0.1225 | |||
| Treynor Ratio | 0.2622 | |||
| Maximum Drawdown | 22.73 | |||
| Value At Risk | (5.73) | |||
| Potential Upside | 9.03 | |||
| Downside Variance | 16.84 | |||
| Semi Variance | 13.28 | |||
| Expected Short fall | (3.81) | |||
| Skewness | 0.6707 | |||
| Kurtosis | 1.38 |
Bright Minds Biosciences Backtested Returns
Bright Minds appears to be very steady, given 3 months investment horizon. Bright Minds Biosciences secures Sharpe Ratio (or Efficiency) of 0.14, which signifies that the company had a 0.14 % return per unit of risk over the last 3 months. By analyzing Bright Minds' technical indicators, you can evaluate if the expected return of 0.66% is justified by implied risk. Please makes use of Bright Minds' Risk Adjusted Performance of 0.1099, mean deviation of 3.46, and Downside Deviation of 4.1 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Bright Minds holds a performance score of 10. The firm shows a Beta (market volatility) of 2.19, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bright Minds will likely underperform. Please check Bright Minds' potential upside, and the relationship between the total risk alpha and kurtosis , to make a quick decision on whether Bright Minds' price patterns will revert.
Auto-correlation | -0.34 |
Poor reverse predictability
Bright Minds Biosciences has poor reverse predictability. Overlapping area represents the amount of predictability between Bright Minds time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bright Minds Biosciences price movement. The serial correlation of -0.34 indicates that nearly 34.0% of current Bright Minds price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.34 | |
| Spearman Rank Test | -0.5 | |
| Residual Average | 0.0 | |
| Price Variance | 38.91 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Bright Minds Correlation, Bright Minds Volatility and Bright Minds Performance module to complement your research on Bright Minds. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Bright Minds technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.